Gynion, LLC is a FemTech startup that is developing therapeutic products for women's health. Our first product is Menorrx treatment for Heavy Menstrual Bleeding (HMB). Menorrx is designed to be a safe and effective endometrial ablation therapy that is simpler, easier to use, and costs a fraction of the available alternatives. It addresses a need for a quick and cost-effective HMB therapy that gynecologists can easily and safely perform in an office setting and avoid unnecessary surgeries for millions of women. This noninvasive treatment presents a substantial opportunity both in developed markets and low-resource countries, where women commonly receive no treatment or undergo a hysterectomy. The preclinical results demonstrate safety and show a lot of promise for high effectiveness. This is a platform technology that presents an opportunity to treat other conditions as well. Our pipeline includes a product for the ablation of cervical intraepithelial neoplasia (CIN) caused by human papillomavirus (HPV). With cervical cancer rates on the rise, this low-cost non-invasive treatment could be offered in the early CIN stages and potentially reverse this trend.Inaccurate data? Flag it here.